tiprankstipranks
Trending News
More News >
Intra-Cellular Therapies (ITCI)
NASDAQ:ITCI
Advertisement

Intra-Cellular Therapies (ITCI) Similar Stocks

Compare
918 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Intra-Cellular Therapies
$131.87
$14.05B
64.04%
4 Buy
9 Hold
0 Sell
Moderate Buy
Dr Reddy's Laboratories
$14.67
$12.20B
18.39
-8.77%
1 Buy
0 Hold
0 Sell
Moderate Buy
Viatris
$9.41
$10.97B
-18.46%
0 Buy
2 Hold
0 Sell
Hold
Neurocrine
$132.14
$13.03B
44.64
-9.99%
21 Buy
2 Hold
0 Sell
Strong Buy
Supernus Pharmaceuticals
$33.58
$1.84B
30.41
9.20%
1 Buy
2 Hold
0 Sell
Moderate Buy
Teva Pharmaceutical
$16.54
$18.81B
-3.27%
7 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ITCI
Intra-Cellular Therapies
131.87
53.68
68.65%
RDY
Dr Reddy's Laboratories
14.67
-1.57
-9.67%
VTRS
Viatris
9.41
-1.95
-17.17%
NBIX
Neurocrine
132.14
-13.11
-9.03%
SUPN
Supernus Pharmaceuticals
33.58
2.99
9.77%
TEVA
Teva Pharmaceutical
16.54
-0.13
-0.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis